Systematic Use of Telepsychiatry for Outpatients

Not Applicable

Completed

• Conditions: Ptsd; Borderline Personality Disorder; Anxiety Disorders; Depressive Disorder
• Interventions: Other: Case management

• Registration Number: NCT05516238
• Lead Sponsor: Psychiatric Research Unit, Region Zealand, Denmark

Brief Summary

Implementation and evaluation of video consultation in psychiatric outpatient treatment. The study will focus on patients' experiences regarding the use of VC. The study will also examine important aspects of the telepsychiatric consultation such as therapeutic alliance, consultation content, psychopathology and satisfaction levels compared to face-to-face consultations.

Detailed Description

Not available

Study Timeline

• Study Start: 2021-04-21
• Primary Completion: 2022-04-26
• Study Completion: 2022-04-26
• Study First Submitted: 2022-05-10
• Study First Submitted QC: 2022-08-23
• Study First Posted: 2022-08-25
• Status Verified: 2023-03
• Last Update Submitted: 2023-03-28
• Last Update Posted: 2023-03-31

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 34

Inclusion Criteria

• age > 18 years
• Danish-speaking.

Exclusion Criteria

• Exclusion criteria included a diagnosis of schizophrenia or bipolar disorder, or suffering from substance abuse.
• Additionally, Participants in the VC group were excluded if they did not have a smartphone, tablet, laptop, or personal computer with a webcam.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
In-person	Case management	Case management through in person format
Video group	Case management	Case management through video format

Primary Outcome Measures

Name	Time	Method
Patients' experiences regarding the use of VC	Two months	Semistructured interviews have been conducted to evaluate participants' experience regarding the use of VC technology in clinical practice.
Patients' well-being, assessed by World Health Organisation- Five Well-Being Index (WHO-5)	Two months.	Well-being level is evaluated with the mean change scores in the WHO-5 questionnaire at baseline and posttreatment. Score ranging: from 0 to 100. Higher scores indicate higher well-being
Patients' function, assessed by Sheehan Disability Scale (SDS)	Two months.	Functional impairment is evaluated with the mean change scores in the SDS questionnaire at baseline and posttreatment. Score ranging: from 0 to 30. lower scores indicate lower functional impairment
The demand for video consultation (VC) in clinical practice.	One year	The demand for VC is evaluated by the percentage of included participants who chose to be in the VC group and the actual use of VC consultation sessions during the study period, including the number of missed appointments and the number of times VC sessions have been converted to telephone or in-person (IP) consultations.
Patients' satisfaction, assessed by client satisfaction questionnaire 8 (CSQ-8)	Two months.	Satisfaction is evaluated with the mean change scores in the CSQ-8 questionnaire at baseline and posttreatment. Score ranging: from 8 to 32. Higher scores indicate a higher satisfaction
Patient recovery, assessed by INSPIRE	Two months.	Patient recovery is evaluated with the mean change scores in the INSPIRE questionnaire at baseline and posttreatment. Score ranging: from 0 to 100. A higher score indicates higher recovery
Patients' therapeutic alliance, assessed by working alliance inventory- client version (WAI-C)	Two months.	Therapeutic alliance is evaluated with the mean change scores in the WAI-C questionnaire at baseline and posttreatment. Score ranging: from 12 to 84. Higher scores indicate a higher therapeutic alliance
The implementation and integration of VC in clinical practice, as assessed by a checklist developed for the case managers (CM).	One year	The following properties are used to evaluate the implementation and integration properties: 1. type of technology patients use for VC sessions (Smartphone/tablet or personal computer/laptop); 2. patients' physical location during VC session (Home or outdoor); 3. the VC sessions confidentiality (Alone or with other persons); 4. duration of VC session; 5. the content of the VC sessions (supportive, therapy, medication management, crisis/acute or "mix" content); Descriptive statistics will be applied to evaluate the implementation and integration properties.
Patients' Symptom level, assessed by Symptom Checklist -10 (SCL-10)	Two months.	Symptom level is evaluated with the mean change scores in the SCL-10 questionnaire at baseline and posttreatment. Score ranging: from 0 to 100. Lower score indicates lower psychological distress

Trial Locations

Locations (1)

Psychiatric research unit, Region Zealand,; 🇩🇰 Slagelse, Denmark